PG
EW icon

PEAK6 Group’s Edwards Lifesciences EW Stock Holding History

PEAK6 Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$265K Buy
+5,466
New +$255K ﹤0.01% 3133
2017
Q4 		– Sell
-45,069
Closed -$1.65M – 4281
2017
Q3 		$1.64M Sell
45,069
-12,795
-22% -$488K 0.01% 1547
2017
Q2 		$2.28M Sell
57,864
-9,180
-14% -$335K 0.01% 1242
2017
Q1 		$2.1M Sell
67,044
-237,375
-78% -$7.43M 0.02% 1100
2016
Q4 		$9.51M Buy
304,419
+183,372
+151% +$5.94M 0.07% 384
2016
Q3 		$4.86M Buy
121,047
+83,631
+224% +$3.15M 0.04% 700
2016
Q2 		$1.24M Sell
37,416
-223,653
-86% -$7.65M 0.01% 1629
2016
Q1 		$7.68M Buy
261,069
+44,487
+21% +$1.23M 0.06% 426
2015
Q4 		$5.7M Buy
216,582
+85,038
+65% +$2.21M 0.04% 651
2015
Q3 		$3.12M Buy
+131,544
New +$3.17M 0.02% 1220
2014
Q2 		– Sell
-8,586
Closed -$116K – 4740
2014
Q1 		$106K Sell
8,586
-44,718
-84% -$516K ﹤0.01% 3890
2013
Q4 		$584K Sell
53,304
-160,020
-75% -$1.8M ﹤0.01% 2539
2013
Q3 		$1.24M Sell
213,324
-69,996
-25% -$819K 0.01% 1955
2013
Q2 		$3.17K Buy
+283,320
New +$3.35M 0.01% 1116

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Group's EW Position: Q2 2018 in Review

PEAK6 Group opened a new position in Edwards Lifesciences (EW) in Q2 2018: 5,466 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #3133 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in EW as recently as Q3 2017.

PEAK6 Group first reported a position in EW in Q2 2013 and has held it in 14 quarters since. The position peaked at $9.51M in Q4 2016. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

  • PEAK6 Group held 5,466 shares of Edwards Lifesciences worth $265K as of Q2 2018.
  • Edwards Lifesciences was a new PEAK6 Group position in Q2 2018.
  • Edwards Lifesciences made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3133 holding.
  • PEAK6 Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 14 quarters since.
  • PEAK6 Group's Edwards Lifesciences position peaked at $9.51M in Q4 2016.
  • 838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.